About: Serum IgG antibodies to peptidylarginine deiminase 4 predict radiographic progression in patients with rheumatoid arthritis treated with tumour necrosis factor-alpha blocking agents

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Serum IgG antibodies to peptidylarginine deiminase 4 predict radiographic progression in patients with rheumatoid arthritis treated with tumour necrosis factor-alpha blocking agents Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 22 August 2008

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) bài báo khoa học (vi) наукова стаття, опублікована в серпні 2008 (uk) im August 2008 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 22 August 2008 (en) artículu científicu espublizáu n'agostu de 2008 (ast)
publication date	wds:Q81820607-21A5E642-75D0-442A-91DA-DACF5F786DCF
publication date	2008-08-22 00:00:00Z (xsd:dateTime)
author name string	wds:Q81820607-29B1E8F5-295F-44F5-BBCB-3C8308A43554 wds:Q81820607-68A17326-1BAD-4FEE-B2D6-764D6CB1D8BF wds:Q81820607-A80DF61C-321F-4B9C-AE73-558B98FE10C2 wds:Q81820607-CEC331D8-4AA1-4ABF-9ED6-D313D6225F19
author name string	D van der Heijde A Boonen S Pollmann E H Halvorsen
rdfs:label	Serum IgG antibodies to peptidylarginine deiminase 4 predict radiographic progression in patients with rheumatoid arthritis treated with tumour necrosis factor-alpha blocking agents (en) Serum IgG antibodies to peptidylarginine deiminase 4 predict radiographic progression in patients with rheumatoid arthritis treated with tumour necrosis factor-alpha blocking agents (nl)
skos:prefLabel	Serum IgG antibodies to peptidylarginine deiminase 4 predict radiographic progression in patients with rheumatoid arthritis treated with tumour necrosis factor-alpha blocking agents (en) Serum IgG antibodies to peptidylarginine deiminase 4 predict radiographic progression in patients with rheumatoid arthritis treated with tumour necrosis factor-alpha blocking agents (nl)
name	Serum IgG antibodies to peptidylarginine deiminase 4 predict radiographic progression in patients with rheumatoid arthritis treated with tumour necrosis factor-alpha blocking agents (en) Serum IgG antibodies to peptidylarginine deiminase 4 predict radiographic progression in patients with rheumatoid arthritis treated with tumour necrosis factor-alpha blocking agents (nl)
author	wds:Q81820607-6526D2CC-04D1-40FF-96A7-28762BF4D842 wds:Q81820607-7CA8FAE6-A1CC-4B74-84DD-3FF37A009941 wds:Q81820607-9D716AC8-20B6-409F-ABB1-32D684898B18
author	Tore K. Kvien Øyvind Molberg Espen A Haavardsholm
title	wds:Q81820607-469B825C-DC0B-4B2B-9D4F-D8D335073924
title	Serum IgG antibodies to peptidylarginine deiminase 4 predict radiographic progression in patients with rheumatoid arthritis treated with tumour necrosis factor-alpha blocking agents (en)
page(s)	wds:Q81820607-92E6CB84-4C6D-457C-80F8-C4F82469E8A9
page(s)	249-252
instance of	wds:Q81820607-DFE1BEF7-31CD-4FC1-BF00-27B3F40721DB
instance of	scholarly article
main subject	wds:Q81820607-6381A49B-1981-4D1A-B8DA-A537855AC404
main subject	rheumatoid arthritis
PubMed ID	wds:Q81820607-94B3B86C-0210-4215-94F6-F77EFC162D47
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/18723564
PubMed ID	18723564
published in	wds:Q81820607-2054B46D-9337-4C95-A8B5-B47EE9E918BF
published in	Annals of the Rheumatic Diseases
issue	wds:Q81820607-257E9AC1-F012-4A78-93EB-2396F8F0D317
volume	wds:Q81820607-52E14481-B6C1-48D6-9BA2-DD63AC7BA6BA
issue	2
volume	68
DOI	wds:Q81820607-332F9943-872C-4310-B436-22A81965B7CD
DOI	http://dx.doi.org/10.1136/ARD.2008.094490
DOI	10.1136/ARD.2008.094490
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q81820607
is cites work of	Associations between APOE genotypes and disease susceptibility, joint damage and lipid levels in patients with rheumatoid arthritis Anti-CCP antibodies: the past, the present and the future Autocitrullination of human peptidyl arginine deiminase type 4 regulates protein citrullination during cell activation Erosive rheumatoid arthritis is associated with antibodies that activate PAD4 by increasing calcium sensitivity Autoimmunity to peptidyl arginine deiminase type 4 precedes clinical onset of rheumatoid arthritis. Heightened immune response to autocitrullinated Porphyromonas gingivalis peptidylarginine deiminase: a potential mechanism for breaching immunologic tolerance in rheumatoid arthritis. Structural damage in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: traditional views, novel insights gained from TNF blockade, and concepts for the future The pathogenic potential of autoreactive antibodies in rheumatoid arthritis. Predominance of IgG1 and IgG3 subclasses of autoantibodies to peptidylarginine deiminase 4 in rheumatoid arthritis Smoking is not linked to the development of anti-peptidylarginine deiminase 4 autoantibodies in rheumatoid arthritis. PAD4 is not essential for disease in the K/BxN murine autoantibody-mediated model of arthritis Association of anti-peptidyl arginine deiminase antibodies with radiographic severity of rheumatoid arthritis in African Americans Prevalence of anti-peptidylarginine deiminase type 4 antibodies in rheumatoid arthritis and unaffected first-degree relatives in indigenous North American Populations. High level of interleukin-32 gamma in the joint of ankylosing spondylitis is associated with osteoblast differentiation Autoantigens as Partners in Initiation and Propagation of Autoimmune Rheumatic Diseases. Anti-PAD4 autoantibodies in rheumatoid arthritis: levels in serum over time and impact on PAD4 activity as measured with a small synthetic substrate Association of Baseline Peptidylarginine Deiminase 4 Autoantibodies With Favorable Response to Treatment Escalation in Rheumatoid Arthritis PAD enzymes in rheumatoid arthritis: pathogenic effectors and autoimmune targets Autoantibodies to Peptidylarginine Deiminase 2 Are Associated With Less Severe Disease in Rheumatoid Arthritis Meta-analysis: diagnostic accuracy of antibody against peptidylarginine deiminase 4 by ELISA for rheumatoid arthritis.
is cites work of	wds:Q34182097-9A61084B-F2F3-4302-BC05-8C517C9EBA7D wds:Q34683913-EAAF7C5F-EC15-415C-B850-4FEAE3FE2566 wds:Q37358849-9BBCD09F-D4E8-48A7-B343-1B6EEB4911BC wds:Q93270547-762CC634-B1B6-4260-9B66-73AC86AD6698 wds:Q37882064-1A9D5DA7-001B-4BC7-ACD7-E2D451E6DF4B wds:Q90207994-FCF7641F-5E6C-4714-A87C-8D58F835D056 wds:Q38206946-1291C71C-4C47-4A62-8FD2-6C5590EAD710 wds:Q34190363-DC5FAAB2-D906-46C1-B300-CB82675DA4DB wds:Q36346823-009C5ACD-431A-4AB9-BE1A-426D13548EAF wds:Q50193229-5AA95FC7-98EE-4E95-95C1-C6FA43E08751 wds:Q37088914-CB1AA316-0C3D-4F85-B11F-330461C97F16 wds:Q37465513-BACD5BD5-3A9F-45F9-B322-90724A9BA57D wds:Q38747090-9F4C3EF4-7CDB-4F4C-A683-88F0D7FD3F8B wds:Q37671218-711F9BF2-3503-416D-A128-C7246EF947A2 wds:Q55257092-E4BFD992-1A4C-4DF1-A554-13300BDF1FAD wds:Q36245934-71207BB4-BB41-4750-A8A5-6132DE065151 wds:Q59791560-6588FBB1-7318-44AB-B03E-593CA02C634E wds:Q41908716-FE34C5FC-370D-4F73-8624-93FDEC9AE571 wds:Q34159040-C52B8A3C-3572-4CC7-A401-50A40BB6DD2F wds:Q83140472-8AF5D9D4-FD0A-47B5-A829-0B941995BD03

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software